Table 2. Effects on Subjective and Objective Outcomes at Week 12 and 24 of Various Factorsa.
Variable | Pain levelb | C-Reactive protein levelc | Erythrocyte sedimentation ratec | |||
---|---|---|---|---|---|---|
Week 12 | Week 24 | Week 12 | Week 24 | Week 12 | Week 24 | |
Baseline | 0.6 (0.5-0.7)d | 0.6 (0.5-0.7)d | −0.001 (−0.002 to −0.001)d | −0.001 (−0.002 to −0.001)d | −0.006 (−0.007 to −0.004)d | −0.005 (−0.007 to −0.002)d |
Sex | 0.7 (−30.5 to 50.0) | 0.5 (−40.6 to 50.5) | 0.101 (−0.137 to 0.340) | −0.066 (−0.432 to 0.301) | −0.081 (−0.189 to 0.026) | −0.050 (−0.183 to 0.084) |
Age | 0.1 (−0.1 to 0.3) | 0.1 (−0.1 to 0.3) | −0.004 (−0.014 to 0.005) | −0.007 (−0.020 to 0.006) | −0.003 (−0.008 to 0.001) | −0.002 (−0.007 to 0.003) |
Randomization ratio | −4.3 (−10 to 10.5) | 0.5 (−120.1 to 130.1) | 0.004 (−0.164 to 0.172) | 0.108 (−0.076 to 0.292) | 0.042 (−0.007 to 0.090) | 0.025 (−0.038 to 0.089) |
Washout length | −0.7 (−10.7 to 0.3) | −0.7 (−20.9 to 10.5) | 0.014 (−0.014 to 0.041) | 0.036 (0.009 to 0.062)d | −0.002 (−0.010 to 0.005) | 0.011 (0.001 to 0.021)d |
Values are presented as effect on the 0- to 100-mm pain scale or on the ratio outcome to baseline for C-reactive protein level and erythrocyte sedimentation rate to account for log-normal distribution.
Positive factors indicate improvement.
Owing to ratio rather than difference calculation, negative factors indicate improvement.
Statistically significant finding.